Toxoplasmic Encephalitis

Immunoblot Testing Effective For Prognosis

Published in AIDS Weekly, July 9th, 2001

by Michael Greer, senior medical writer - Researchers have shown that immunoglobulin G (IgG) immunoblot testing for Toxoplasma gondii is an effective means of determining patients at high risk for developing toxoplasmic encephalitis (TE), a common central nervous system infection among AIDS patients.

Catherine Leport and colleagues at the Xavier Bichat Faculty of Medicine in France and other institutions conducted a study comparing different prognostic indicators of high TE risk. Their results were published in the journal Clinical and Diagnostic Laboratory Immunology.

Immunoblot testing provided the most reliable marker of elevated TE...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2001-07-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry